- Home
- LGVN vs JNVR Comparison
LGVN vs JNVR Comparison
Compare LGVN & JNVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- JNVR
- Stock Information
- Founded
- LGVN 2014
- JNVR 2018
- Country
- LGVN United States
- JNVR United States
- Employees
- LGVN N/A
- JNVR N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- JNVR Finance: Consumer Services
- Sector
- LGVN Health Care
- JNVR Finance
- Exchange
- LGVN Nasdaq
- JNVR Nasdaq
- Market Cap
- LGVN 30.0M
- JNVR N/A
- IPO Year
- LGVN 2021
- JNVR 2023
- Fundamental
- Price
- LGVN $2.05
- JNVR $0.55
- Analyst Decision
- LGVN Strong Buy
- JNVR
- Analyst Count
- LGVN 2
- JNVR 0
- Target Price
- LGVN $8.00
- JNVR N/A
- AVG Volume (30 Days)
- LGVN 393.9K
- JNVR 21.7K
- Earning Date
- LGVN 11-08-2024
- JNVR 11-12-2024
- Dividend Yield
- LGVN N/A
- JNVR N/A
- EPS Growth
- LGVN N/A
- JNVR N/A
- EPS
- LGVN N/A
- JNVR N/A
- Revenue
- LGVN $1,229,000.00
- JNVR $1,786,085.00
- Revenue This Year
- LGVN $161.78
- JNVR N/A
- Revenue Next Year
- LGVN $8.62
- JNVR N/A
- P/E Ratio
- LGVN N/A
- JNVR N/A
- Revenue Growth
- LGVN 39.34
- JNVR N/A
- 52 Week Low
- LGVN $0.77
- JNVR $0.42
- 52 Week High
- LGVN $23.90
- JNVR $1.84
- Technical
- Relative Strength Index (RSI)
- LGVN 52.20
- JNVR 49.64
- Support Level
- LGVN $1.76
- JNVR $0.49
- Resistance Level
- LGVN $2.26
- JNVR $0.62
- Average True Range (ATR)
- LGVN 0.12
- JNVR 0.06
- MACD
- LGVN 0.05
- JNVR -0.00
- Stochastic Oscillator
- LGVN 58.00
- JNVR 58.69
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.